Compared to other breast cancer subtypes, TNBC exhibits higher levels of tumour-infiltrating lymphocytes (TILs), programmed cell death-ligand 1 (PD-L1) expression, and increased tumour mutational burden (TMB) [13] (refer to Figure 1). The gene discussed is CD274; the disease is neoplasm.